Pantoprazole vs Rosuvastatin: side-by-side comparison
Pantoprazole (Proton pump inhibitor) and Rosuvastatin (HMG-CoA reductase inhibitor (statin)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Pantoprazole | Rosuvastatin |
|---|---|---|
| Therapeutic class | Proton pump inhibitor | HMG-CoA reductase inhibitor (statin) |
| CAS | 102625-70-7 | 287714-41-4 |
| ATC | A02BC02 | C10AA07 |
| Molecular weight | 383.37 g/mol | 481.54 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Pantoprazole and Rosuvastatin share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Pantoprazole acts by a different mechanism than Rosuvastatin, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Pantoprazole: Pantoprazole is a substituted benzimidazole prodrug activated in the acidic environment of the gastric parietal cell, where it irreversibly inhibits the H+/K+-ATPase enzyme — the proton pump responsible for the final ste… Rosuvastatin: Rosuvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis.
Indications compared
Pantoprazole: Pantoprazole is approved in adults and children for the treatment of gastro-oesophageal reflux disease, including erosive oesophagitis healing and maintenance, peptic ulcer disease, prevention of NSAID-induced ulcers, Zo… Rosuvastatin: Rosuvastatin is approved in adults for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia, for the prevention of cardiovascular events in patients at elevated risk and for the secondary prevention of…
Safety profile
Pantoprazole: Common adverse effects include headache, gastrointestinal symptoms and dizziness. Rosuvastatin: Common adverse effects include myalgia, gastrointestinal symptoms, headache and mild elevations of liver enzymes.
Frequently asked questions
Is Pantoprazole better than Rosuvastatin? ▾
Pantoprazole and Rosuvastatin are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Pantoprazole and Rosuvastatin be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Pantoprazole
Products with Rosuvastatin
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.